ABOUT NANOFORM
Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners to improve the lives of patients globally by overcoming drug development and delivery challenges through its game-changing nanoforming technologies, novel formulation capabilities and GMP manufacturing facilities. The company’s dedicated, multi-disciplinary team has a combined experience of launching 100+ medicines. Its services span the small to large molecule development space with a focus on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.
FEATURED CONTENT
CONTACT INFORMATION
Nanoform
Cultivator II, Viikinkaari 4
Helsinki, FI-00790
FINLAND
Phone: +1-414-403-0635
Contact: Sergie Letser, VP US Business Development
FEATURED NEWS
- Nanoform, Celanese Demonstrate Enhanced Drug Delivery
- FIMEA Renews Nanoform’s GMP License And Nanoform Starts Clinical API Manufacturing Of A Blockbuster Medicine Candidate
- TargTex To Presents Tumour Eradication From Nanoformed Glioblastoma Drug
- Pharmanovia Partnership To Breathe New Life Into Iconic Medicines
- "STARMAP® Online" Offers Medicine Developers AI-Power
- Rising Demand Spurs GMP Capacity Increase & Added Handling Capabilities
- Nanoform Technology Delivers Successful Results For Herantis CDNF Drug Candidate
- Nanoform’s Final Clinical Results Confirm Value Proposition To The Pharma Industry
- Nanoform And Aprecia Collaborate To Advance 3D Printed Nanomedicines
- Nanoform Launches Next-Generation STARMAP® V2.0, The AI-Based Drug Candidate Selection Tool For CESS®
- Nanoform And Herantis Sign Biologics Proof Of Concept Agreement
- Nanoform And Herantis Partner To Look For Opportunities To Enhance BBB Penetration Of CDNF And xCDNF Molecules
